This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Review
Biology of RANK, RANKL, and osteoprotegerin
Arthritis Research & Therapy 2007, 9(Suppl 1):S1 doi:10.1186/ar2165
No comments have yet been made on this article.
